Digital Go-To-Market - Sustainably successful market access for digital healthcare products.

DTx and go-to-market are a blue ocean to many. However, there are yet things to be learnt from the competition. We help to understand trends, pitfalls and the true potential behind the latest headlines. ⬢

Spotlight

Advanced Diabetes Technology Landscape 2025

18. March 2025

The Advanced Diabetes Technology Landscape 2025 is an extensive overview of companies shaping the future of diabetes care.

Whitepaper: Digital Health Applications (DiGA) in Portugal

25. June 2024

The whitepaper "Digital Health Applications (DiGA) in Portugal," explores the necessity and current status of implementing a DiGA framework in Portugal, offering expert insights and strategic recommendations for enhancing healthcare through digital solutions.

Webinar | Digital Devices in Pediatrics

24. May 2024

Discover the Transformative Reimbursement Pathways in Pediatric Healthcare through Our Engaging Webinar. Learn about the key aspects, benefits, and processes for achieving reimbursement for innovative healthcare solutions.

New Levers in Pharmaceutical Field Force

18. April 2024

The sales force is and remains an essential sales driver for pharmaceutical companies. But not just since the coronavirus has it become clear that the traditional sales force is in urgent need of an update.

Advanced Diabetes Technology Landscape 2024

4. March 2024

The Advanced Diabetes Technology Landscape 2024 is an extensive overview of companies shaping the future of diabetes care.

MARKET ANALYSIS

Knowing your own strategy is good – understanding what happens outside your own organization is better.

The German healthcare system is currently undergoing a substantial transformation towards a digitally connected and more efficient environment. Such far-reaching developments typically put established players under pressure and create space for growth of new market entrants. In either case it is important to be aware of the short-term to long-term trends and their implications. Digital Oxygen supports its healthcare clients in understanding the true potential behind latest headlines also quantitatively and on deriving areas for own growth.

COMPETITIVE ANALYSIS

Typically, medical health products compete not only with other services, but also with already existing therapy approaches.

In many healthcare case, the need for therapy is currently increasing, as is openness to digital treatment approaches. This may prompt a large number of established and new competitors to launch their own innovative offerings on the market. In addition, competitors are now competing not only for attention at the point of care, but also in the virtual space. We help manufacturers of digital health products understand their competitors’ moves and provide in-depth analysis on the topics critical for success.

REGULATORY ANALYSIS

When launching new medical devices, regulatory requirements play a crucial role.

From an outside-in-perspective the German healthcare system appears promising but complex. Depending on the targeted sector (ambulatory care, elderly care or hospitals) very specific regulatory frameworks have evolved over the years. Additionally, a multitude of digitalization programs come on-top with own requirements. Together with a network of sector-specialists, Digital Oxygen guides its local, regional and international clients around common regulatory pitfalls for a successful digital go-to-market.

MARKET ACCESS PATH CONSULTING

In many cases there is more than one path to reimbursement – often they can be combined or build on each other.

Currently DiGA is the most prominent market access path followed for digital therapeutics in Germany. However, depending on the company’s vision and mission alternative paths may make more sense (for the moment). The German healthcare system offers various market access opportunities. We help our clients gain clear understanding of the different available paths in terms of benefits, challenges, time-to-market and cost among other relevant aspects. We also give actionable recommendations on where to start and which paths to iteratively leverage for an efficient way into reimbursement.

BUSINESS CASE MODELLING

Thorough business cases create transparency and are the key to investors’ and project sponsors’ trust

When initiating the roll-out of digital healthcare products qualitative assessments are typically taken to narrow down the number of available market access paths. Once taking the plans to actionable levels and securing corresponding funds, business case become relevant. Digital Oxygen supports its clients on developing substantial growth business cases and quantitatively underpinning these with tangible drivers. This includes editable excel models as well as visualized driver (trees) assessment. Also a neutral, 3^rd party verification of existing business cases and underlying assumptions in terms of evidence and aggressiveness as part of Commercial Due Diligence processes are among our services.